Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,682,997 | $2,621,163 | $1,152,490 | $1,898,907 |
| - Cash | $183,049 | $226,316 | $286,470 | $378,687 |
| + Debt | $75,572 | $85,026 | $94,069 | $94,912 |
| Enterprise Value | $1,575,520 | $2,479,873 | $960,089 | $1,615,132 |
| Revenue | $376,572 | $312,974 | $245,109 | $203,565 |
| % Growth | 20.3% | 27.7% | 20.4% | – |
| Gross Profit | $191,002 | $133,349 | $89,729 | $84,235 |
| % Margin | 50.7% | 42.6% | 36.6% | 41.4% |
| EBITDA | -$52,098 | -$176,705 | -$174,151 | -$211,680 |
| % Margin | -13.8% | -56.5% | -71.1% | -104% |
| Net Income | -$77,670 | -$208,726 | -$204,618 | -$217,863 |
| % Margin | -20.6% | -66.7% | -83.5% | -107% |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 |
| % Growth | 63.9% | 0% | 10.9% | – |
| Operating Cash Flow | -$47,628 | -$64,094 | -$142,474 | -$124,385 |
| Capital Expenditures | -$28,004 | -$5,076 | -$27,779 | -$101,857 |
| Free Cash Flow | -$75,632 | -$69,170 | -$170,253 | -$226,242 |